At Mumbai’s Chowpatty Beach, sea facing buildings tower over an effigy of ‘Ravana’ waiting to be burnt to symbolize the victory of good over evil. The paradox of India is its extreme disparity. While poverty is a fact of everyday life, the real estate prices are sky-high, perhaps higher than first world cities.
Subscribe to Blog via Email
Join 463 other subscribers
- L&T Finance has consistently delivered strong growth. Target Price ₹230 (25%)L&T Finance has consistently delivered strong growth. It has invested in process automation, security & customer journeys. This, along with partnerships with e-aggregators, should lead to a stronger & more sustainable retail loan growth. TP ₹230 (25%)... L&T Finance has consistently delivered strong growth. Target Price ₹230 (25%)
- Dolly Khanna has invested in 1.63% of Emkay Global. Investment is worth ₹6.65 CrDolly Khanna has invested in 1.63% of Emkay Global. Investment is worth ₹6.65 Cr. Co is a play on broking, investment banking & wealth management. Promoters hold 75%. In FY 24, PMS+AIF AUMs increased by 38% YoY to ₹9,023 mn. Wealth AUMs increased by 42% YoY to ₹31,772 mn. ... Dolly Khanna has invested in […]
- Top Bank Stocks with a strong balance sheet and formidable retail deposit franchise To Buy NowInvestment implications: We reiterate our conviction on banks with a strong balance sheet and formidable retail deposit franchise, which are likely to continue gaining market share, with ICICIBC (BUY, TP: INR 1,325), SBIN (BUY, TP: INR 1,040), and KMB (BUY, TP: INR 2,025) being our top picks amongst large banks. https://rakesh-jhunjhunwala.in/top-...retail-deposit-franchise-to-buy-now-hdfc-sec/
Recent Posts
- Pre Budget Expectations 2024-25 by HDFC Securities
- Piramal Pharma is at critical inflection point and expect overall improvement as the CDMO momentum continues. BUY for target price of ₹210 (42% upside): ICICI Direct
- L&T Finance Earnings in line; strong retail momentum continues NIM improves ~15bp QoQ; asset quality stable. Target Price ₹230 (25% upside): Motilal Oswal
- Downgrade Defence Sector on Super Rich Valuations: Nirmal Bang
- JB Pharma offers a healthy cocktail of a robust domestic franchise, niche CMO presence and measured exports strategy, Buy for target price of ₹2025 (15% upside): Kotak Securities
Recent Comments
- anil on Ace Stock Picker Maheen Rahman Recommends Mega Multibagger Stocks Which Will Be “Next HDFC Bank, Kotak Bank”
- Shaileshbhai Rajwadi on Kenneth Andrade reveals his latest stock picks & strategy for 2024. He is very bullish about Pharma, Liquor and Metal stocks but is avoiding banking stocks
- Surineni Sudhakar on Sunil Singhania’s (Abakkus) purchase of 6.7% of Shriram Pistons appears to be because of its EV prospects
- Anil on Prashant Jain has invested in a portfolio of promising small and nano-cap stocks from different sectors.
- Anil on Prashant Jain has invested in a portfolio of promising small and nano-cap stocks from different sectors.
Leave a Reply